Notably, ITGA1 has been identified as a pro-malignant biomarker in pancreatic cancer, promoting drug resistance and metastatic potential (Gharibi et al., 2017) (Figure 4e). The gene discussed is ITGA1; the disease is pancreatic neoplasm.